Rishi Sunak had a great pandemic.
The UK Prime Minister reportedly earned $710 million through his investment company Theleme buying shares in unknown vaccine manufacturer Moderna, less that a year before it became a major player in the 'Pandemic'.
Moderna, who formed in 2018, only had one product. An MRNA 'vaccine' that, until a year later, was a cure without an illness. Sunak, via Theleme, invested heavily in the company at launch and In July of 2018, the company opened a 200,000 square foot facility in Norwood, Massachusetts for manufacturing, preclinical and clinical work.
Although they only had one (experimental) product that had never been commercially sold, Sunak invested heavily in the company that, just 12 months later, would be spearheading the pandemic response.
The pandemic was said to be a 'black-swan' event yet Sunak had incredibly, not only invested in an unknown company with the 'cure', he managed to do so just months before the black swan event happened.
In May 2019, the company together with Merck Sharp & Dohme, entered a Phase I clinical trial for mRNA-5671 vaccine in combination with pembrolizumab for the treatment of solid tumors with driver mutations in the KRAS gene.[31]
On the 12th December 2019 (some 19 Days BEFORE the supposed discovery of Covid-19) Moderna provided an ‘mRNA coronavirus vaccine candidate’ developed jointly by NIAID and Moderna, to The University of North Carolina for evaluation.
In November 2020, UK-based Daily Mirror reported that Theleme gained after Moderna's stock soared from £4.7 billion to £32 billion due to its Covid vaccine. It said the UK government bought five million doses of the Moderna vaccine in November of that year only.
The same month UK newspaper The Guardian asked Sunak if he had benefited from the investment, but should have asked how the hell he knew that the one and only product from an unknown manufacturer was suddenly going to make him billions to combat a black swan event that is only supposed to happen once in a lifetime.
As of November 7, 2022, Theleme's top holding was 6,004,406 shares of Moderna worth over $710 million and making up 34.6 per cent of the portfolio value.
Carol Vorderman, a media personality and author, recently shared an old report by the Financial Times on the UK's £1 billion deal with Moderna to build the country's first manufacturing centre for messenger RNA vaccines. Sharing the story, she said Sunak as Chancellor signed the deal with Moderna. "He still refuses to say if he profited from this deal via holdings in his hedge fund Theleme which owned £1 billion of Moderna shares," she said.
Rishi Sunak's Hedge Fund is reported to have invested in Moderna before the company was listed on the Nasdaq stock exchange in 2018, meaning that he must have had prior knowledge that a 'black swan' event was imminent, with all the implications that has.